# Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis

> **NCT05633706** · — · RECRUITING · sponsor: **Nimble Science Ltd.** · enrollment: 300 (estimated)

## Conditions studied

- Irritable Bowel Syndrome
- Crohn Disease
- Celiac Disease
- Ulcerative Colitis
- Functional Dyspepsia
- Type 2 Diabetes
- Healthy

## Interventions

- **DEVICE:** fluid biopsy capsule

## Key facts

- **NCT ID:** NCT05633706
- **Lead sponsor:** Nimble Science Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-09
- **Primary completion:** 2025-06-06
- **Final completion:** 2025-06-06
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-04-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05633706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05633706, "Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05633706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*